Answers are grounded in this paper and cite their sources.
Background: The vaccination of dialysis patients against hepatitis B is a standard of care. Data suggests that seroconversion following this vaccination is poor in dialysis patients. Methods: The authors compared the response of 67 incident dialysis patients who had received the hepatitis B vaccination to that of healthy subjects. Results: The authors found that only 60% of haemodialysis patients vaccinated against hepatitis B developed an immune response. Conclusions: Haemodialysis patients have a suboptimal response to hepatitis B vaccinations as compared to that of general population.
No takes yet. Share an insight, caveat, or question.
Dsouza et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: